메뉴 건너뛰기




Volumn 7, Issue 1, 2010, Pages 4-7

Mexico at the vanguard: A new era in medicines of biotechnological origin

(1)  Boardman, Ernesto Saro a  

a NONE   (Mexico)

Author keywords

Access to biotech medicines at affordable prices; Amendment to Article 222 Bis of the general health law; Biocomparable medicines; Innovative biotechnological medicines

Indexed keywords

BIOTECHNOLOGY DRUG; DRUG; UNCLASSIFIED DRUG;

EID: 75949099176     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/jgm.2009.38     Document Type: Short Survey
Times cited : (1)

References (1)
  • 1
    • 75949100815 scopus 로고    scopus 로고
    • When a drug costs $300 000. Editorial -23
    • March
    • New York Times. (2008) When a drug costs $300 000. Editorial -23 March.
    • (2008) New York Times


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.